These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6175803)

  • 21. Alinidine in angina.
    Meinertz T; Kasper W; Meier R; Wiegand U; Bechtold H; Förster I; Pop T; Jähnchen E
    Clin Pharmacol Ther; 1983 Dec; 34(6):770-6. PubMed ID: 6641092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic actions on alinidine during exercise in patients with coronary artery disease.
    Löllgen H; Just H; Wollschläger H; Kersting F
    Z Kardiol; 1981 May; 70(5):425-8. PubMed ID: 7269729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alinidine pharmacokinetics following acute and chronic dosing.
    Harron DW; Arndts D; Shanks RG
    Br J Clin Pharmacol; 1982 Jun; 13(6):821-7. PubMed ID: 7093113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing.
    Verdouw PD; Saxena PR; Schamhardt HC; van der Hoek TM; Rutteman AM
    Eur J Pharmacol; 1980 Jun; 64(4):209-20. PubMed ID: 7389819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of catecholamine-induced tachycardia with alinidine in the anesthetized dog.
    Benjamin E; Paluch TA; Berger SR; Plawker M; Kaplan JA; Iberti TJ
    J Cardiothorac Anesth; 1987 Aug; 1(4):309-12. PubMed ID: 17165313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of alinidine on experimental cardiac arrhythmias.
    Harron DW; Allen JD; Wilson R; Shanks RG
    J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
    Kawada M; Satoh K; Taira N
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pacemaker selectivity: influence on rabbit atria of ionic environment and of alinidine, a possible anion antagonist.
    Millar JS; Williams EM
    Cardiovasc Res; 1981 Jun; 15(6):335-50. PubMed ID: 7296591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular effects of N-allyl clonidine (ST 567, alinidine): a substance with specific bradycardiac action during neuroleptanesthesia in humans.
    Fitzal S; Zimpfer M
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):404-7. PubMed ID: 7141760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of M & B 17803A, a new -adrenoceptor blocking agent, on the cardiovascular responses to tilting and to isoprenaline in man.
    Cuthbert MF; Owusu-Ankomah K
    Br J Pharmacol; 1971 Nov; 43(3):639-48. PubMed ID: 4400530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiac electrophysiologic effects of alinidine, a specific bradycardic agent, in the conscious dog: plasma concentration-response relations.
    Boucher M; Chassaing C; Chapuy E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):229-33. PubMed ID: 7752648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
    Uprichard AC; Chi LG; Lynch JJ; Driscoll EM; Frye JW; Lucchesi BR
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):475-82. PubMed ID: 2476629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on atrio-ventricular conduction of alinidine and falipamil injected into the AV node artery of the anesthetized dog.
    Takeda M; Furukawa Y; Ogiwara Y; Saegusa K; Haniuda M; Akahane K; Chiba S
    Arch Int Pharmacodyn Ther; 1989; 297():39-48. PubMed ID: 2730241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative chronotropic and parasympatholytic effects of alinidine on canine sinus node and AV junction.
    Hageman GR; Neely BH; Urthaler F; James TN
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H324-30. PubMed ID: 3976903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alinidine in heart patients: electrophysiologic and antianginal actions.
    Meinertz T; Kasper W; Jähnchen E
    Eur Heart J; 1987 Dec; 8 Suppl L():109-14. PubMed ID: 3330524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemodynamic effects of alinidine (ST 567) at rest and during exercise in patients with chronic congestive heart failure.
    Koenig W; Stauch M; Sund M; Wanjura D; Henze E
    Am Heart J; 1990 Jun; 119(6):1348-54. PubMed ID: 2353620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alinidine in chronic stable angina: the effect on diastolic perfusion time.
    Ferro G; Spinelli L; Duilio C; Spadafora M; Cinquegrana G; Condorelli M
    Cardiology; 1990; 77(4):287-94. PubMed ID: 2073645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies of alinidine induced bradycardia in the presence of caesium.
    Dennis PD; Williams EM
    Cardiovasc Res; 1986 May; 20(5):375-8. PubMed ID: 3756979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.